COVID-19 vaccination induces highly variable immunity among the immunocompromised
Researchers in the United States have conducted a study showing that the humoral (antibody) immunity induced by vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – varies significantly among immunocompromised individuals.
The findings come from an interim analysis of an ongoing observational, prospective cohort analysis called the COVID-19 Vaccination in the Immunocompromised Study (CoVICS), which began on April 14
th, 2021.
Ghady Haidar and colleagues report that the presence of antibodies (seropositivity) against SARS-CoV-2 was significantly lower among certain groups of immunocompromised individuals compared with among healthy vaccinees.
Study: Immunocompromised Response to COVID-19 Vaccination miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.